Our Pharmaceutical Director, Dr Gerry Kenna, recently presented a virtual seminar on “In vitro models for assessment of drug-induced liver injury (DILI): a personal perspective” to the Liver Toxicity Working Group of the US regulator, the FDA
Our Research Consultant, Dr Pandora Pound is speaking this afternoon at the 11th World Congress on Alternatives and Animal Use in the Life Sciences, on “Breaking the lock-in to animal research within academia”.
Our Scientific Consultant, Rebecca Ram, spoke at the 11th World Congress on Alternatives and Animal Use in the Life Sciences on “New Approach Methodologies Funding and Regulation”.
In a recent webinar our Director Dr Jan Turner, described why gaps in this data either through selective reporting or omission of significant data all together, can have profound effects on the decision-making of regulatory agencies and ultimately lead to unsafe drugs being placed on the market.
Presentation by Dr Jan Turner
Continue reading “Current regulatory guidelines and technological development of 3D models: Closing the gap”
“The future for UK regulation of medicines, medical devices and clinical trials – transparency and public trust, safety and enforcement, and support for innovation” was the subject of a recent Westminster Health Forum meeting at which our Director, Dr Jan Turner described why innovation and the development of methods to ensure safe and effective medicines, is imperative for the UK now and importantly, post Brexit.
Hosted by the Physicians Committee for Responsible Medicine, in conjunction with US Congresswoman Lucille Roybal-Allard, our Pharmaceutical Director, Dr Gerry Kenna, recently spoke on why “Human-relevant models are needed to understand and treat human COVID-19 disease” at PCRM’s Congressional hearing “Confronting COVID-19: A Briefing on Prioritizing Human-Based Research”. A recording of the event is here and Dr Kenna’s slides are here.
Hear our Director Dr Jan Turner speak about barriers and progress to adoption of human relevant in vitro models in drug discovery at the Advances in Cell and Tissue Culture conference in Cardiff, June 2019
Dr Jan Turner speaking at the March 8th 2019 London Conference to launch the book:
Dr Bob Coleman, UK Science Director of Safer Medicines Trust, also spoke at the Conference on ‘Humanising Drug Safety Testing’ – view his presentation